These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26676886)
21. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. Ally MS; Ransohoff K; Sarin K; Atwood SX; Rezaee M; Bailey-Healy I; Kim J; Beachy PA; Chang AL; Oro A; Tang JY; Colevas AD JAMA Dermatol; 2016 Apr; 152(4):452-6. PubMed ID: 26765315 [TBL] [Abstract][Full Text] [Related]
22. Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro. Wang C; Li B; Zhang H; Shi G; Li W; Jonas JB Ophthalmic Res; 2007; 39(6):302-7. PubMed ID: 17957129 [TBL] [Abstract][Full Text] [Related]
23. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer. Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463 [TBL] [Abstract][Full Text] [Related]
24. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143 [TBL] [Abstract][Full Text] [Related]
25. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro. Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315 [TBL] [Abstract][Full Text] [Related]
26. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway. Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876 [TBL] [Abstract][Full Text] [Related]
27. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide. Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882 [TBL] [Abstract][Full Text] [Related]
28. Antitumor effects of arsenic trioxide in transformed human thyroid cells. Fröhlich E; Czarnocka B; Brossart P; Wahl R Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326 [TBL] [Abstract][Full Text] [Related]
29. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. Eichenmüller M; Hemmerlein B; von Schweinitz D; Kappler R Br J Cancer; 2010 Jun; 103(1):43-51. PubMed ID: 20517313 [TBL] [Abstract][Full Text] [Related]
30. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902 [TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921 [TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207 [TBL] [Abstract][Full Text] [Related]
33. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway. Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890 [TBL] [Abstract][Full Text] [Related]
34. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28). Giri U; Terry NH; Kala SV; Lieberman MW; Story MD Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769 [TBL] [Abstract][Full Text] [Related]
35. 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways. Estañ MC; Calviño E; de Blas E; Boyano-Adánez Mdel C; Mena ML; Gómez-Gómez M; Rial E; Aller P Biochem Pharmacol; 2012 Dec; 84(12):1604-16. PubMed ID: 23041229 [TBL] [Abstract][Full Text] [Related]
36. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp. Han B; Zhou G; Zhang Q; Zhang J; Wang X; Tang W; Kakudo K J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663 [TBL] [Abstract][Full Text] [Related]
37. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928 [TBL] [Abstract][Full Text] [Related]
38. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo. Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026 [TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines. Mayer BFB; Stagno MJ; Fuchs J; Warmann SW; Schmid E Anticancer Res; 2023 Mar; 43(3):1025-1030. PubMed ID: 36854509 [TBL] [Abstract][Full Text] [Related]
40. Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells. Oue T; Uehara S; Yamanaka H; Nomura M; Usui N Pediatr Surg Int; 2013 Nov; 29(11):1153-8. PubMed ID: 23989521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]